Abstract:Background: Myopia and especially high myopia are recognised as major public health concerns. Although the prevalence of high myopia in young children is low, 10-20% of high school children in Asia have high myopia, with many still progressing, and one in three patients with high myopia develop visual impairment with age. Most participants in myopia control studies have low and moderate myopia; relatively little is known about myopia control in high myopia. Method: Literature searches were undertaken in MEDLINE and EMBASE to identify publications in English, investigating (Aim 1) the efficacy of myopia control strategies (environmental, pharmacological and optical) in high myopia (≤-6.00 D) and (Aim 2) the complications of high myopia using keywords. Outcomes included change in spherical equivalent refractive error (SE) and/or axial length (AL) to evaluate progression in high myopia. Results: Aim 1: Twelve studies were identified that reported the efficacy of optical and pharmacological (none on environmental) interventions on AL and SE for high myopia control. A statistically significant reduction in progression of SE and AL in high myopes was reported with 1% and 0.5% atropine. Defocus Incorporated Multiple Segment spectacle lenses had lower efficacy in slowing high myopia progression compared to moderate and low myopia. Ortho-K lenses were equally effective in reducing myopia progression in low, moderate and high myopia. Aim 2: Myopic patients have an increased risk of myopic macular degeneration, retinal detachment, cataract and glaucoma, with the risk increasing with the level of myopia. Conclusions: High myopia has significant effects on quality of life, risk of pathological complications and vision impairment. Young children, excluding those with some syndromic associations, who are fast progressing moderate and high myopes require early intervention and close monitoring. Further research investigating the efficacy of myopia control strategies in highly myopic patients, both independently and through combination treatments, are necessary.

Prevention of Myopia Progression in Children and Adolescents

IMI Prevention of Myopia and Its Progression

Pathogenesis and Prevention of Worsening Axial Elongation in Pathological Myopia

Myopia: Mechanisms and Strategies to Slow Down Its Progression

Prevention of Progression in Myopia: A Systematic Review

Optics of spectacle lenses intended to treat myopia progression

Advances in myopia control strategies for children

Juvenile myopia progression, risk factors and interventions

Author Correction: Synergistic Effects of Defocus-Incorporated Multiple Segments and Atropine in Slowing the Progression of Myopia

Myopia control: Seeing beyond efficacy

Myopia and orthokeratology for myopia control

[Atropine for the Prevention of Progression in Myopia - Data, Side Effects, Practical Guidelines]

Optic treatments to myopia management

Pharmaceutical intervention for myopia control

Retardation of Myopia Progression by Multifocal Soft Contact Lenses

Effect of spectacle lenses designed to reduce relative peripheral hyperopia on myopia progression in Japanese children: a 2-year multicenter randomized controlled trial

Epidemiology of Myopia

High myopia: Reviews of myopia control strategies and myopia complications

The Role of Atropine Eye Drops in Myopia Control

Current and emerging pharmaceutical interventions for myopia

Effective Decrease in Myopia Progression With Two Mechanisms of Management